Navigation Links
Shire plc: Continued Strong Product Sales Performance in Q3: On Track to Deliver Significant 2011 Earnings Growth
Date:10/28/2011

gain on disposal of investment in Vertex ($23.5 million), and tax effect of adjustments; and

d)Depreciation: Depreciation of $85.2 million included in Cost of product sales, R&D costs and SG&A costs for US GAAP separately disclosed for the presentation of Non GAAP earnings.


 

Unaudited results for the nine months to September 30, 2010

Non GAAP reconciliation

US GAAP Adjustments Non GAAP Acquis Divestments, Amorti itions & reorgan September -zation integr -izations & Reclas September 9 months to, 30, & asset -ation discontinued -sify 30, 2010 impairments activ operations deprec 2010 -ities -iation (a) (b) (c) (d) $M $M $M $M $M $M Total revenues 2,539.9 - - - - 2,539.9 Costs and expenses: Cost of product sales 333.7 - - (21.9) (8.6) 303.2 Research and development 475.9 - (45.0) - (11.6) 419.3 Selling, general and administrative 1,106.7 (142.3) - - (49.0) 915.4 Gain on sale of product rights (4.1) - - 4.1 - - Reorganization costs 23.3 - - (23.3) - - Integration and acquisition costs 6.4 - (6.4) - - - Depreciation - - - - 69.2 69.2 Total operating expenses 1,941.9 (142.3)(51.4) (41.1) - 1,707.1 Operating income 598.0 142.3 51.4 41.1 - 832.8 Interest income 1.9 - - - - 1.9 Interest expense (25.6) - - - - (25.6) Other income/(expense), net 9.0 - - (11.1) - (2.1) Total other expense, net (14.7) - - (11.1) - (25.8) Income before income taxes and equity in earnings of equity method investees 583.3 142.3 51.4 30.0 - 807.0 Income taxes (160.8) (29.4) (3.6) (9.1) - (202.9) Equity in earnings of equity method investees, net of tax 0.2 - - - - 0.2 Net income 422.7 112.9 47.8 20.9 - 604.3 Impact of convertible debt, net of tax 25.2 - - - - 25.2 Numerator for diluted EPS 447.9 112.9 47.8 20.9 - 629.5 Weighted average number of shares (millions) - diluted 589.7 - - - - 589.7 Diluted earnings per ADS 228.0c 57.3c 24.3c 10.6c - 320.2c

The following items are included in Adjustments:

'/>"/>
SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

Related biology technology :

1. NHS Northamptonshire Chief Executive John Parkes Accepts Visiting Professorship
2. FDA Approves Shires FIRAZYR® (icatibant injection) for Acute Attacks of Hereditary Angioedema (HAE)
3. Shires Quarterly Revenues Grow by 25% to $1 Billion for the First Time
4. Shire Files Lawsuits Against Watson and Roxane for Infringement of VYVANSE(R) (lisdexamfetamine dimesylate) Patents
5. Shire Presents Data at ACMG for Fabry and Gaucher Patients Who Switched to Replagal® (agalsidase alfa) and VPRIV® (velaglucerase alfa for injection)
6. Shire Reports Positive Signal Finding Study of Investigative Use of Vyvanse(R) (lisdexamfetamine dimesylate) Capsules as Adjunctive Treatment in Major Depressive Disorder
7. Shire plc: Continued Excellent Performance in Q3, Full Year Earnings Expectations Increased, New Value in Pipeline Emerging
8. Shire Announces Results of the Tender Offer for Movetis NV and Commencement of Squeeze-Out Tender Period
9. Reportlinker Adds Shire plc: PharmaVitae Profile
10. Shire Announces European Approval of VPRIV(R) (velaglucerase alfa) for the Treatment of Type 1 Gaucher Disease
11. Shire plc - Statement re ProAmatine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... 2014 Reportlinker.com announces that a new ... Global Chelating Agents Market 2014-2018 ... Chelating Agent A chelating agent is a chemical ... ions, thereby forming a metal-ion complex. It reduces ... chemical processes, formulations, and the environment by chelating ...
(Date:8/27/2014)... Aug. 27, 2014 Guggenheim Securities, the investment ... announced the hiring of veteran equity analyst Charles "Tony" ... Mr. Butler will focus on the biotech/biopharma sector. ... wealth of experience and a broad network of relationships ... Managing Director and Head of Equities at Guggenheim Securities. ...
(Date:8/27/2014)... 2014  ARCH Venture Partners, one of the ... development of seed and early-stage advanced technology companies, ... with more than $400 million in subscriptions. ARCH ... target by more than $150 million. ... and potential of our approach to finding and ...
(Date:8/27/2014)... August 27, 2014 According to the ... to reshape the look and feel of markets for ... for higher-quality ingredients will push for more branded, science-backed ... have experienced strong market growth in the last decade ... their food and cosmetics to fit a more ‘wellness’ ...
Breaking Biology Technology:Global Chelating Agents Market 2014-2018 2Global Chelating Agents Market 2014-2018 3Global Chelating Agents Market 2014-2018 4Guggenheim Securities Hires Analyst Charles "Tony" Butler to Expand Healthcare Coverage 2Latest ARCH Venture Partners Fund Closes Above $400 Million 2Latest ARCH Venture Partners Fund Closes Above $400 Million 3Daring to be Different Raw Materials & Ingredient Supply Shortage Fuels Vital Force™ Technology New Ingredient Enhancements 2Daring to be Different Raw Materials & Ingredient Supply Shortage Fuels Vital Force™ Technology New Ingredient Enhancements 3
... Whitewater, Wis. - The University of Wisconsin-Whitewater has ... what is now known as the Information Technology Infrastructure ... Computer End-User Technologies program, is a product of joint ... will begin this fall semester. It places a far ...
... Metavante Corp., the financial technology subsidiary of Marshall ... June, of Wayne, Pa.-based GHR Systems, Inc. , ... mortgage and consumer finance industries that offers point-of-sale products ... Systems will become a Metavante subsidiary. , ,GHR's client ...
... - Southern Wisconsin's biotech infrastructure has prompted a ... an operating facility that could employ approximately 200 people. ... the southern tier of Wisconsin to manufacture systems used ... CEO Dan Miller. It's a product that company representatives ...
Cached Biology Technology:Whitewater upgrades tech degree program 2Whitewater upgrades tech degree program 3Minneapolis company sets sights on southern Wisconsin 2Minneapolis company sets sights on southern Wisconsin 3
(Date:8/27/2014)... a dreaded bacterium that can be found in both ... 28 persons in Denmark have been infected with ... have died. , The bacterium is notoriously difficult to ... adapt to changes in its surroundings, says Associate Professor ... from the Department of Biochemistry and Molecular Biology, she ...
(Date:8/26/2014)... Researchers at Washington University in St. Louis have developed ... bones prone to tearing or breaking. The technology, which ... patients, one day may help pinpoint minor strains and ... problems occur. , The research is available online Aug. ... Interface , which publishes research at the nexus of ...
(Date:8/26/2014)... obtaining an unprecedented view of a type of ... of neurological illnesses, including Alzheimer,s disease, Parkinson,s disease, ... stroke. , The team of biologists at Cold ... Energy,s Advanced Photon Source at Argonne National Laboratory ... NMDA (N-methyl, D-aspartate) receptor should serve as template ...
Breaking Biology News(10 mins):Researchers discover why Listeria bacterium is so hard to fight 2Researchers discover why Listeria bacterium is so hard to fight 3New technology may identify tiny strains in body tissues before injuries occur 2New technology may identify tiny strains in body tissues before injuries occur 3Unprecedented detail of intact neuronal receptor offers blueprint for drug developers 2Unprecedented detail of intact neuronal receptor offers blueprint for drug developers 3
... from McGill/MUHC and the CHUM have been awarded ... Institutes of Health Research (CIHR) to continue their ... during sexual intercourse. The new funding will allow ... and statistician/epidemiologists, to root-out the cause of a ...
... at Case Western Reserve University School of Medicine and University ... (FDA) has approved plans to begin a study to evaluate ... to treat chronic ischemia, a serious form of heart disease. ... to test the safety of the procedure. It will ...
... leading neuroscientist at MIT and one from the University ... Nov. 4 special issue of Science dedicated to the ... "protocortex" theories of brain development are dead. , The ... neurons divided into distinctly separate areas that process particular ...
Cached Biology News:MUHC investigators search for the root of sexual pain in women 2Feds give researchers ok for safety test of adult stem cells in patients with heart disease 2MIT researcher presents new view of how the cortex forms 2
... Best: DASGIPs Process Control integrates Process ... comprehensive documentation for cultivation processes. A ... pH, dissolved oxygen, temperature and agitation ... Profiles, e.g. constant or scheduled media ...
... LC Sciences provides a genome-wide microRNA ... and proprietary probe design, which enable highly ... (1-3). We have standard arrays for mature ... latest version of the Sanger miRBase database ...
... synthetic peptide whose sequences are derived from mouse resistin protein. ... - S - M - P - L - C - ... - D - K - K - I - K - ... used for neutralization and control experiments with the polyclonal antibody that ...
... Imaging System, Basic Package Superior Protein ... Range: The ProXPRESS 2D Proteomic Imaging System ... for both proteomic and general life science ... enabling the use of all dyes in ...
Biology Products: